"Whoa, this stock is on a rocket ride with no news brakes! 🚀 The 9-day WMA just punched through the 21-day like it’s nothing, and RSI is flirting with overbought (74.6)—but hey, momentum loves company. Volume’s juicing up on up days, and the chart’s got that ‘stairs to heaven’ vibe. No news? No problem—this beast is running on FOMO. BUY the dip if you can find one! #FOMOExpress"

Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.

Biocon Limited BIOCON.NS: 392.65 INR

Bullish views